TITLE

Monitoring exhaled nitric oxide to guide inhaled steroid dosage in asthma

AUTHOR(S)
Currie, G. P.
PUB. DATE
September 2005
SOURCE
Thorax;Sep2005, Vol. 60 Issue 9, p739
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents information on a study published in the "New England Journal of Medicine," which evaluated whether exhaled nitric oxide (NO) can help to identify optimum inhaled corticosteroid doses. Ninety seven asthmatics were randomised into a 1 year single blind, placebo controlled trial. Individuals had their inhaled corticosteroid dose altered at regular intervals, either on the basis of conventional parameters alone or with knowledge of their exhaled NO concentration. The researchers conclude that, with the help of exhaled NO measurements, inhaled corticosteroid doses can be successfully titrated down without loss of asthma control.
ACCESSION #
18366927

 

Related Articles

  • Beclazone.  // Royal Society of Medicine: Medicines;2002, p100 

    The article presents information on beclazone, a proprietary, prescription-only preparation of the corticosteroid and beclometasone dipropionate. It can be used to prevent asthmatic attacks, and is available in an aerosol for inhalation.

  • Beclazone Easi-Breathe.  // Royal Society of Medicine: Medicines;2002, p100 

    The article presents information on beclazone easi-breathe, a proprietary, prescription-only preparation of the corticosteroid beclometasone dipropionate. It can be used to prevent asthma attacks and is available in forms for aerosol inhalation with breath-actuated units.

  • Asthma meds: Getting to the right answer. Corjulo, Michael // Contemporary Pediatrics;Jul2007, Vol. 24 Issue 7, p87 

    The article offers tips about asthma medications from a medical professional. He states that when asking patients about their adherence to their medication regime, patients' answers can be too vague to be of any use. He offers that when he talks to an older child about the use of controller...

  • Becloforte.  // Royal Society of Medicine: Medicines;2002, p100 

    The article presents information on becloforte, a proprietary, prescription-only preparation of the corticosteroid beclometasone dipropionate. It can be used to prevent asthma attacks, and is available in various forms with inhalers and a dry powder used with the Diskhaler.

  • Comparison of Respiratory Status 3 VS 4 Hours After Bronchodilator Therapy In Hospitalized Asthmatics. Uy, Vincent; Erichsen, Daniel; Smith, Alyson; Pina, Paulo; Rubin, David // New York Medical Journal (2154-9400);Summer2014, Vol. 8 Issue 2, p1 

    The article cites a prospective study of pediatric patients 2-20 years old who were admitted for an acute asthma exacerbation from January 2012 to June 2013 in a urban community hospital. The aim of the study was to compare vital signs and respiratory physical examination findings 3 hours and 4...

  • Moderately high dose still need to be considered for very young children. Cochran, D.P. // Archives of Disease in Childhood;Jun2003, Vol. 88 Issue 6, p555 

    Presents a letter to the editor of 'Archives of Disease in Childhood,' addressing the question of adrenal suppression when using higher doses of inhaled corticosteroid. Existence of limited data on intra-pulmonary drug deposition in children under three years; Rationale for using higher doses...

  • Effects of fluticasone plus salmeterol versus twice the dose of fluticasone in asthmatic patients. Currie, Graeme P.; Bates, Caroline E.; Lee, Daniel K. C.; Jackson, Catherine M.; Lipworth, Brian J. // European Journal of Clinical Pharmacology;May2003, Vol. 59 Issue 1, p11 

    Objective. Current guidelines advocate adding a long acting β2-agonist (LABA) to an inhaled corticosteroid as an alternative to increasing the dose of the latter. Since it is unclear how this translates into effects on surrogate inflammatory markers, we evaluated the anti-inflammatory...

  • Exhaled nitric oxide thresholds associated with a sputum eosinophil count ≥3% in a cohort of unselected patients with asthma. Florence N Schleich // Thorax;Dec2010, Vol. 65 Issue 12, p1039 

    BACKGROUND: It has been claimed that exhaled nitric oxide (FeNO) could be regarded as a surrogate marker for sputum eosinophil count in patients with asthma. However, the FeNO threshold value that identifies a sputum eosinophil count ≥3% in an unselected population of patients with asthma...

  • Beclometasone Dipropionate/Formoterol in an HFA-Propelled Pressurised Metered-Dose Inhaler. Barnes, Peter J. // Drugs;2006, Vol. 66 Issue 11, p1484 

    The article reports on the treatment of asthma. The combination of corticosteroid inhalers and B2-agonist are considered the most effective treatments of asthma and in other chronic obstructive pulmonary diseases. Some of the examples of B2-agonists are fluticasone propionate, salmeterol and...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics